Axogen Announces First Surgical Implants of Avive+ Soft Tissue Matrix™
Provided By GlobeNewswire
Last update: Apr 29, 2024
ALACHUA, Fla. and TAMPA, Fla., April 29, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, announces the first surgical implantations of its newest product, Avive+ Soft Tissue Matrix™.
